The fatigue and breathlessness program specific to interstitial lung disease is feasible, acceptable, and clinically effective.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results